The Nasdaq was down 0.17% to 3,155 in midday trading Tuesday, while the Dow Jones Industrial Average fell 0.18% to 13,535.
The S&P 500 was off 0.14% to 1,455.
The yield on a 10-year treasury bond was down 0.17% to 1.72%.
The price of gold was up 0.06% to $1,766 per ounce.
Shares of Tustin-based drug developer Peregrine Pharmaceuticals Inc. rose about 49% to $1.73. The rise came a day after the stock plummeted 78% on a company report of discrepancies in trial results for its core drug bavituximab. Today’s gains put Peregrine’s market value at about $177 million.